Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer Biomarker”

2,963 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,963 results

Not applicableStudy completedNCT06479434
What this trial is testing

Serum Biomarker Levels Improvement in Poly Cystic Ovarian Syndrome: Impact of Metformin Compared to Healthy Controls

Who this might be right for
Polycystic Ovary SyndromeInsulin Resistance
Aga Khan University 110
Not applicableLooking for participantsNCT07297134
What this trial is testing

PTEN and Organ-Specific microRNAs in Metastatic Breast Cancer

Who this might be right for
Breast CancerMetastatic Breast CancermiRNAs+1 more
Atlas University 160
Not applicableStudy completedNCT06607809
What this trial is testing

Inflammatory Markers (ICC, MCVL) and Nivolumab Response: Predicting Immunotherapy Success in Metastatic RCC

Who this might be right for
Metastatic Renal Cell Carcinoma
Dr. Lutfi Kirdar Kartal Training and Research Hospital 99
Testing effectiveness (Phase 2)Study completedNCT00828984
What this trial is testing

Macrogol 3350-based Oral Osmotic Laxative in Preventing Cancer in Patients at Risk of Colorectal Cancer

Who this might be right for
Adenomatous PolypColorectal Carcinoma
National Cancer Institute (NCI) 87
Large-scale testing (Phase 3)Active Not RecruitingNCT02785952
What this trial is testing

Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers

Who this might be right for
Recurrent Squamous Cell Lung CarcinomaStage IV Squamous Cell Lung Carcinoma AJCC v7
SWOG Cancer Research Network 275
Not applicableActive Not RecruitingNCT04964271
What this trial is testing

Identification of Prostate Cancer Specific Markers in Patients Compared to Healthy Participants

Who this might be right for
Prostatic Neoplasms
Tethis S.p.A. 60
Not applicableStudy completedNCT04879316
What this trial is testing

Energy for Lymphocytes

Who this might be right for
Non-small Cell Lung CancerProgression, Disease
Hôpital Cochin 144
Not applicableStudy completedNCT02605512
What this trial is testing

BreAst Cancer and Cardiotoxicity Induced by RAdioTherapy: the BACCARAT Study

Who this might be right for
Breast CancerCardiac Toxicity
Sophie JACOB 118
Not applicableLooking for participantsNCT06818149
What this trial is testing

Biomarkers for Clinical Classification and Outcomes of Immune Checkpoint Inhibitor-Related-Related Myocarditis in Lung Cancer

Who this might be right for
Lung CancerMyocarditis Due to Drug
Shanghai Chest Hospital 50
Not applicableNot Yet RecruitingNCT07042867
What this trial is testing

Prospective Multicenter Cohort Study for the Development and Evaluation of Risk Stratification Tools for Lung Cancers and Their Postoperative Recurrences Using Multimodal Clinical, Radiological, Tissue and Longitudinal Biological Phenotyping Among People at Risk of Lung Cancer

Who this might be right for
Lung Cancer (Diagnosis)
Assistance Publique Hopitaux De Marseille 900
Not applicableEnded earlyNCT06347809
What this trial is testing

DNA Methylation in Adenocarcinoma of the Prostate: Analysis of Validated Biomarkers in Urine

Who this might be right for
Prostate AdenocarcinomaProstate Carcinoma
Mayo Clinic 24
Not applicableUnknownNCT06227416
What this trial is testing

Skin Tumor Biomarkers by Mass Spectrometry Imaging

Who this might be right for
Skin CancerSquamous Cell CarcinomaBasal Cell Carcinoma+1 more
Bispebjerg Hospital 300
Not applicableStudy completedNCT01643148
What this trial is testing

The Tetrad BMI, Leptin, Leptin/Adiponectin (L/A) Ratio and CA-15-3 is a Reliable Biomarker of Breast Cancer

Who this might be right for
Female Breast Carcinoma
Materno-Perinatal Hospital of the State of Mexico 88
Testing effectiveness (Phase 2)Study completedNCT02422498
What this trial is testing

Homologous Recombination Repair Status as a Biomarker of Response in Locally Recurrent/Metastatic Triple Negative Breast Cancer Patients Treated With Concurrent Cisplatin and Radiation Therapy

Who this might be right for
Locally Recurrent/Metastatic Triple Negative Breast Cancer
Memorial Sloan Kettering Cancer Center 49
Not applicableStudy completedNCT01138306
What this trial is testing

Biomarkers in Samples From Young Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
Children's Oncology Group 149
Not applicableEnded earlyNCT00923052
What this trial is testing

The Natural History of Solid Organ Cancer Stem Cells (SOCSC)

Who this might be right for
Hepatic CancerPancreatic Ductal CancerColorectal Cancer+2 more
National Cancer Institute (NCI) 190
Not applicableLooking for participantsNCT02279004
What this trial is testing

A Prospective Study of Plasma Genotyping as a Noninvasive Biomarker for Genotype-directed Cancer Care

Who this might be right for
NSCLCMelanoma
Dana-Farber Cancer Institute 840
Not applicableStudy completedNCT02944617
What this trial is testing

Probiotic Yogurt Supplement in Reducing Diarrhea in Patients With Metastatic Kidney Cancer Being Treated With Vascular Endothelial Growth Factor-Tyrosine Kinase Inhibitor

Who this might be right for
DiarrheaMetastatic Renal Cell CarcinomaStage IV Renal Cell Cancer
City of Hope Medical Center 21
Not applicableUnknownNCT03814811
What this trial is testing

Circulating Osteocalcin-positive Cells in Breast Cancer Bone Metastasis

Who this might be right for
Breast NeoplasmsBone Metastases
Seoul National University Hospital 200
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06595563
What this trial is testing

HER2 Molecular Imaging With 89Zr-trastuzumab PET/CT as a Predictive Biomarker for Antibody-drug Conjugate Sequencing in Patients With Advanced HER2-positive Breast Cancer

Who this might be right for
HER2-positive Metastatic Breast CancerHER2-positive Advanced Breast Cancer
Jules Bordet Institute 87
Load More Results